Phil,
Let's see if I can answer your post in 100 words or less. Oops, I already used 13 words in my last sentence lol.
<Do you have secretaries assembling your posts, or do you do it all yourself?>
I think for myself and type my own posts.
<Have you ever responded to a simple post in less than 100 words?>
Yes, and I believe that I answered your questions in a few words. Most of my last post was answering Mad2. Perhaps I should have split it into two posts, one to you and one to him.
<Are you now, or have you ever been, compensated by GUMM or any of it's affiliated companies for your posts or support?>
Absolutely not. I have never been paid any money, stock, or other compensation from Gum Tech or any of its affiliates for any purpose. I am simply a concerned shareholder with a large position in the stock.
<How do you answer questions like I posted in the detail that you answered without insider information?>
I don't think that any of my answers required material information. Can you please be more specific on which part of my last post leads you to believe that I have inside information. I do not possess any material inside information about Gum Tech or any of its affiliates.
<Are you a GUMM insider that is only compensated by the value of the equity?>
I am not a Gum Tech insider, Gum Tech employee, Gum Tech agent, Gum Tech consultant (did I leave anything out? lol) and I am not compensated by them in any way.
<I am short this POS and if it ever trades at 50 to 60 per share for more than a week without a reverse split, I will kiss your ass in public at a location of your choice.>
Are you a good looking female? How about just a female? If not, then thanks but no thanks lol.
The stock market isn't always rational and stocks can trade to unreasonable prices in the short term. Who would have thought that investors would push VPHM from $5 to $110 or CIEN from $8 to $170? The market is entirely nuts at times and it is possible that GUMM could trade to 50 or 60 if the clinical studies are published in a reputable journal and backed by a reputable researcher. The short interest in GUMM was up to 1.2 million shares as of February and I suspect that it is even higher now. If good news is released and John Q Public gets behind the stock, anyone that is short could get screwed royally. The question is at what price would people offer to sell stock if shorts and new longs are jumping over each other to buy the stock. I'm not saying this to scare anyone. I'm saying it in all honesty and sincerely hope that nobody gets hurt too badly IF it happens. I don't know for a fact that it will happen, but I suspect that it will. Where else are the clinical results that were due in October 99? Oops, I used up my quota of words. lol
Regards,
Dan |
